Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease.

@article{Mueller2003CoenzymeQS,
  title={Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease.},
  author={Thomas Mueller and Thomas B{\"u}ttner and Ali Farshad Gholipour and Wilfried Kuhn},
  journal={Neuroscience letters},
  year={2003},
  volume={341 3},
  pages={201-4}
}
Features of Parkinson's disease (PD) include oxidative stress, nigral mitochondrial complex I deficiency and visual dysfunction, all of which are also associated with coenzyme Q(10) (CoQ(10)) deficiency. The objective of this monocenter, parallel group, placebo controlled, double-blind trial was to determine the symptomatic response of daily oral application of 360 mg CoQ(10) lasting 4 weeks on scored PD symptoms and visual function, measured with the Farnsworth-Munsell 100 Hue test (FMT), in… CONTINUE READING

From This Paper

Topics from this paper.
47 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 47 extracted citations

Similar Papers

Loading similar papers…